NuGen Files Patent for Ready-to-Fill COP/COC Needle-Free Injection Nozzle, Advancing Prefilled Nozzle Technology
Toronto, Ontario--(Newsfile Corp. - March 25, 2026) - NuGen Medical Devices Inc. (TSXV: NGMD) ("NuGen"), a leader in needle-free drug delivery, today announced the filing of a new patent covering a Ready-to-Fill (RTF) COP/COC injection nozzle designed specifically for pharmaceutical needle-free applications. The nozzle, which is the subject of a newly filed patent application, represents a novel pharmaceutical packaging component that enables needle-free injection using established ase
Healthcare and Hospitals, Pharmaceuticals, Health
2026-03-25 5:15 PM EDT | NuGen Medical Devices Inc.
Governance Professionals of Canada Celebrates 4th Annual Governance Professionals Day, Spotlighting Next Gen Governance Leaders and a TMX Market Close with Ivey Business School
Toronto, Ontario--(Newsfile Corp. - March 25, 2026) - Governance Professionals of Canada (GPC) is proud to celebrate Governance Professionals Day (GP Day) on March 25, marking the fourth nationwide recognition of the essential role governance professionals play in shaping responsible, transparent, and accountable organizations. This year's theme reflects GPC's recent launch of the Next Gen Governance Professionals Initiative, a na
Banking / Financial Services, Education, Healthcare and Hospitals, Oil & Gas
2026-03-25 10:21 AM EDT | Governance Professionals of Canada
Familywood Releases New Clinical Guide to Support Families Affected by Addiction
Penticton, British Columbia--(Newsfile Corp. - March 25, 2026) - Familywood, a virtual clinical counselling practice dedicated exclusively to families affected by addiction, has released a complimentary, evidence-informed guide designed to support families navigating the complex realities of loving someone with addiction. "Families are often deeply impacted and the least supported in the context of addiction," said Dr. Zach Walsh, Clinical Psychologist and Professor, University of Briti
2026-03-25 10:00 AM EDT | Familywood Family Support Services Inc.
Discovery Senior Living Establishes Chief Performance Officer Group to Drive NOI Expansion, Asset Optimization, and Predictive Performance Across National and Regional Communities
Bonita Springs, Florida--(Newsfile Corp. - March 24, 2026) - Discovery Senior Living ("Discovery" or the "Company") and its affiliated subsidiaries, one of the most trusted and the largest privately held senior housing operators in the U.S., is pleased to provide an update on its recently announced appointment of Tom Costello to Chief Performance Officer. This is a new role and functional group under Tom marking the next stage in the Company's platform evolution following the recent ap
Healthcare and Hospitals, Real Estate, Housing
2026-03-24 2:08 PM EDT | Discovery Senior Living
Tonight: Adia Nutrition and UCF CARD Host Live Zoom on Revolutionary Stem Cell Study for Autism - Strong Interest Already Building
Winter Park, Florida--(Newsfile Corp. - March 24, 2026) - Adia Nutrition Inc. (OTCQB: ADIA), a leader in regenerative medicine through its Adia Med division, is excited to announce a special virtual Zoom presentation happening tonight, Tuesday, March 24, 2026, at 6:00 PM EDT, with the Center for Autism and Related Disabilities (CARD) at the University of Central Florida (UCF). This high-impact session will deliver critical information directly to families, caregivers, and professionals
Healthcare and Hospitals, Health
2026-03-24 8:00 AM EDT | Adia Nutrition Inc.
Envoy Medical Reports Full Year 2025 Financial Results
Received FDA approval to expand fully implanted Acclaim® Cochlear Implant Pivotal Clinical Trial to final stage Strengthened balance sheet by extinguishing $32 million in debt Subsequent to year-end, closed on transformational capital raise led by established institutional healthcare investors and completed enrollment of Pivotal Clinical Trial for first-of-its-kind fully impla
Biotechnology, Healthcare and Hospitals
2026-03-23 8:30 AM EDT | Envoy Medical, Inc.
Phio Pharmaceuticals Announces American Academy of Dermatology 2026 Presentation Featuring Clinical Study Results from Study of PH-762 for Cutaneous Carcinoma Underscoring Clinical Pipeline Advancement
King of Prussia, Pennsylvania--(Newsfile Corp. - March 23, 2026) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage siRNA biopharmaceutical company developing therapeutics using its proprietary INTASYL® gene silencing technology to eliminate cancer. Phio announced today that a podium presentation addressing its lead product candidate, PH-762, will be given in the American Academy of Dermatology's Late-Breaking Research Session S034 on March 28, 2026 in Denver, Col
Biotechnology, Healthcare and Hospitals, Pharmaceuticals, Health
2026-03-23 7:00 AM EDT | Phio Pharmaceuticals Corp.
HEALWELL AI Delivers Record Revenue and First Year of Positive Adjusted EBITDA as Global AI Platform Strategy Takes Hold
Record revenue growth - HEALWELL achieved record annual revenue from continuing operations of approximately $103.8 million in fiscal 2025, an increase of 427% compared to the $19.7 million in fiscal 2024. The Company reported an IFRS net loss from continuing operations of $39.1 million in fiscal 2025, compared to a net loss of $24 million in fiscal 2024. First full year of positive Adjusted EBITDA - HEALWELL delivered Adjusted EBITDA o
Technology, Healthcare and Hospitals
2026-03-19 7:00 AM EDT | HEALWELL AI
TIME Names medmix as one of "World's Best Companies for Sustainable Growth 2026"
medmix AG Neuhofstrasse 20 CH-6430 Baar communications@medmix.com www.medmix.swiss DOWNLOAD MEDIA RELEASE
Technology, Construction / Building, Healthcare and Hospitals, Household / Consumer / Cosmetics
2026-03-18 4:07 AM EDT | medmix AG
Resverlogix Announces Delay in Filing of Annual Financial Statements, AIF, and MD&A
Calgary, Alberta--(Newsfile Corp. - March 17, 2026) - Resverlogix Corp. (TSX: RVX) ("Resverlogix" or the "Company") today announces that because of delays in the completion of its year-end audit, the Company anticipates it will be unable to meet the prescribed deadline of March 31, 2026 for filing of the following continuous disclosure documents (collectively, the "Annual Filings"): Annual Audited Financial Statements, Annual Information Form, and M
Technology, Biotechnology, Healthcare and Hospitals
2026-03-17 10:49 PM EDT | Resverlogix Corp.
ALST Announces Formal Offer to Acquire 55% Stake in Imperia Calcio
Sunny Isles Beach, Florida--(Newsfile Corp. - March 17, 2026) - ALST (OTCID: ALST) is pleased to formally announce that a strategic offer has been placed to acquire a 55% ownership stake in Imperia Calcio, in collaboration with a team of distinguished investors. This proposal represents a significant step in ALST's continuing commitment to fostering growth in the sports industry and supporting the future development of Imperia Calcio, a club with a rich history and passionate fanbase. T
Healthcare and Hospitals, Retail, Health
2026-03-17 11:31 AM EDT | Allstar Health Brands, Inc.
Healthcare Technology Research Company, KLAS Research, Reports 100% of Surveyed Customers Would Buy Vectramind Health's Firstpass Platform Again
Dubai, United Arab Emirates--(Newsfile Corp. - March 17, 2026) - Vectramind Health today announced that its AI-native patient experience and engagement platform, Firstpass, has received strong validation in a newly released KLAS First Look report highlighting high levels of customer satisfaction and measurable improvements in patient engagement and operational efficiency. The findings, published in the KLAS Research report 'Vect
Technology, Healthcare and Hospitals, Pharmaceuticals
2026-03-17 10:06 AM EDT | Vectramind Health
Adia Med of Winter Park Appoints Amy Dalrymple, APRN, Former Mrs. Florida United States, to Lead Regenerative Aesthetics Division
Winter Park, Florida--(Newsfile Corp. - March 17, 2026) - Adia Nutrition Inc. (OTCQB: ADIA) is proud to announce that its subsidiary, Adia Med of Winter Park, has appointed Amy Dalrymple, MSN, APRN, FNP-C, a highly experienced aesthetic nurse practitioner and former Mrs. Florida United States, as the leader of its new Regenerative Aesthetics Division.
Healthcare and Hospitals, Health
2026-03-17 9:30 AM EDT | Adia Nutrition Inc.
Theralase(R) Discovers Further Mechanism on How Ruvidar(R) Inactivates Herpes Simplex Virus
Toronto, Ontario--(Newsfile Corp. - March 17, 2026) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical stage pharmaceutical company, dedicated to the research and development of energy-activated small molecules for the safe and effective destruction of cancer, bacteria and viruses, is pleased to announce the discovery of an additional Mechanism Of Action ("MOA") as to how Ruvidar® is
Technology, Biotechnology, Healthcare and Hospitals, Pharmaceuticals
2026-03-17 7:00 AM EDT | Theralase Technologies Inc.
Phio Pharmaceuticals Announces "A Groundbreaking Approach to Treating Skin Cancer" in a Fireside Chat with Force Family Office
King of Prussia, Pennsylvania--(Newsfile Corp. - March 16, 2026) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage siRNA biopharmaceutical company developing therapeutics using its proprietary INTASYL® gene silenc
Biotechnology, Healthcare and Hospitals, Pharmaceuticals, Health
2026-03-16 11:30 AM EDT | Phio Pharmaceuticals Corp.
Cosmo Highlights Leadership in Real Time Medical AI at NVIDIA GTC 2026
Dublin, Ireland--(Newsfile Corp. - March 16, 2026) - Cosmo Pharmaceuticals N.V. (SIX: COPN) (FSE: C43) (“Cosmo”) today announced its participation at NVIDIA GTC 2026, the world’s leading conference for artificial intelligence (AI) and accelerated computing, taking place in San Jose (CA), USA, from March 16 to March 19. At the conference, Cosmo will present a technical session titled “Engineering Medical Grade Platforms for Real Time AI
Healthcare and Hospitals, Health
2026-03-16 2:09 AM EDT | Cosmo Pharmaceuticals N.V.
Healthcare Special Opportunities Fund Announces March 2026 Quarterly Distribution
Toronto, Ontario--(Newsfile Corp. - March 13, 2026) - LDIC Inc. (TSX: MDS.UN) (the "Manager"), the manager of Healthcare Special Opportunities Fund (the "Fund"), a closed-end investment fund, today announces the quarterly distribution of CDN$0.06161 per Class A unit and US$0.05573 per Class U unit. The distribution will be paid on or before April 10, 2026, to unitholders of record on March 31, 2026. For further information please conta
Banking / Financial Services, Healthcare and Hospitals
2026-03-13 11:01 AM EDT | Healthcare Special Opportunities Fund
HEALWELL AI Reaches 47 Peer-Reviewed Publications, Strengthening Its Scientific Moat for AI-Powered Real-World Clinical Evidence Generation
HEALWELL achieves its 47th total peer-reviewed publication validating its DARWEN™ AI across multiple disease areas and diverse patient populations. HEALWELL presented new scientific validation of DARWEN™ AI at the European Crohn's and Colitis Organisation (ECCO) meeting, with findings published in the Journal of Crohn's and Colitis(1). The study conducted with the U.S. affiliate of a large pharmaceutical partner, demonstrated how A
Technology, Healthcare and Hospitals
2026-03-12 3:15 AM EDT | HEALWELL AI
Bachem Reports Strong Sales Growth and Sustained High Profitability
Bubendorf, Switzerland--(Newsfile Corp. - March 12, 2026) - Ad hoc announcement pursuant to Art. 53 LR Bachem Reports Strong Sales Growth and Sustained High Profitability Group sales increase to CHF 695.1 million in 2025 (+14.8%, in local currencies +19.2%). EBITDA increases to CHF 214.7 million (+21.8%, in local currencies +32.6%). EBITDA margin lies at 30.9%. Adjusted for one-time effects of CHF 16.1 milli
Biotechnology, Chemical, Healthcare and Hospitals, Pharmaceuticals
2026-03-12 1:59 AM EDT | Bachem Holding AG
Cosmo Presents Agenda for AGM 2026
Dublin, Ireland--(Newsfile Corp. - March 12, 2026) - Cosmo Pharmaceuticals N.V. (“Cosmo”) is pleased to announce the convening of its upcoming Ordinary Annual General Meeting of Shareholders (AGM) to be held on 10 April 2026 in Amsterdam. The agenda includes, among others, the following discussion and voting items: Report of the Board of Directors on the business year 2025 and the ESG achievements Appropri
Healthcare and Hospitals, Health
2026-03-12 1:58 AM EDT | Cosmo Pharmaceuticals N.V.